NASDAQ:SGRY Surgery Partners - SGRY Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Surgery Partners, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $31.65 -0.19 (-0.60%) (As of 03/23/2023 04:00 PM ET) Add Compare Share Share Today's Range$31.11▼$32.7550-Day Range$30.11▼$35.9452-Week Range$20.46▼$63.87Volume357,048 shsAverage Volume688,311 shsMarket Capitalization$3.99 billionP/E RatioN/ADividend YieldN/APrice Target$42.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Surgery Partners MarketRank™ ForecastAnalyst RatingModerate Buy2.71 Rating ScoreUpside/Downside34.3% Upside$42.00 Price TargetShort InterestBearish8.12% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.53Based on 3 Articles This WeekInsider TradingSelling Shares$2.41 M Sold Last QuarterProj. Earnings Growth65.00%From $0.40 to $0.66 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.13 out of 5 starsMedical Sector618th out of 986 stocksGeneral Medical & Surgical Hospitals Industry5th out of 5 stocks 3.4 Analyst's Opinion Consensus RatingSurgery Partners has received a consensus rating of Buy. The company's average rating score is 2.71, and is based on 5 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $42.00, Surgery Partners has a forecasted upside of 34.3% from its current price of $31.28.Amount of Analyst CoverageSurgery Partners has only been the subject of 3 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted8.12% of the float of Surgery Partners has been sold short.Short Interest Ratio / Days to CoverSurgery Partners has a short interest ratio ("days to cover") of 7.Change versus previous monthShort interest in Surgery Partners has recently decreased by 1.06%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldSurgery Partners does not currently pay a dividend.Dividend GrowthSurgery Partners does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SGRY. Previous Next 2.5 News and Social Media Coverage News SentimentSurgery Partners has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.34 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Surgery Partners this week, compared to 2 articles on an average week.Search InterestOnly 3 people have searched for SGRY on MarketBeat in the last 30 days. This is a decrease of -63% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Surgery Partners to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Surgery Partners insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,410,750.00 in company stock.Percentage Held by InsidersOnly 3.30% of the stock of Surgery Partners is held by insiders. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Surgery Partners are expected to grow by 65.00% in the coming year, from $0.40 to $0.66 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Surgery Partners is -53.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Surgery Partners is -53.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSurgery Partners has a P/B Ratio of 1.34. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Surgery Partners (NASDAQ:SGRY) StockSurgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.Read More Receive SGRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address SGRY Stock News HeadlinesMarch 18, 2023 | benzinga.comSurgery Partners Chief Growth Officer Sold $172K In Company StockMarch 18, 2023 | americanbankingnews.comInsider Selling: Surgery Partners, Inc. (NASDAQ:SGRY) CEO Sells 10,300 Shares of StockMarch 23, 2023 | Oxford Club (Ad)My No. 1 dividend stock for a LIFETIME of income.Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.March 17, 2023 | americanbankingnews.comBradley R. Owens Sells 1,669 Shares of Surgery Partners, Inc. (NASDAQ:SGRY) StockMarch 16, 2023 | benzinga.comSurgery Partners Recent Insider ActivityMarch 7, 2023 | msn.comSurgery Partners's Return On Capital Employed InsightsMarch 6, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Gilead Sciences (GILD) and Surgery Partners (SGRY)March 4, 2023 | benzinga.comSurgery Partners Insider Trades Send a SignalMarch 23, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.March 3, 2023 | msn.comSurgery Partners' Fourth-Quarter Performance to Give Investors Confidence but Outlook Could 'Prove Conservative,' RBC SaysMarch 3, 2023 | finance.yahoo.comSurgery Partners, Inc. (NASDAQ:SGRY) Q4 2022 Earnings Call TranscriptMarch 2, 2023 | finance.yahoo.comThose who invested in Surgery Partners (NASDAQ:SGRY) three years ago are up 180%March 1, 2023 | finance.yahoo.comSurgery Partners (SGRY) Q4 Earnings and Revenues Top EstimatesMarch 1, 2023 | msn.comSurgery Partners Non-GAAP EPS of $0.27 beats by $0.09, revenue of $707.1M beats by $18.45MMarch 1, 2023 | finance.yahoo.comSurgery Partners, Inc. Announces Fourth Quarter and Full Year 2022 Results; Sets 2023 GuidanceFebruary 28, 2023 | finance.yahoo.comSurgery Partners Stock Gets Technical Rating UpgradeFebruary 23, 2023 | nasdaq.comSGRY Makes Notable Cross Below Critical Moving AverageFebruary 23, 2023 | uk.finance.yahoo.comSurgery Partners, Inc. (SGRY)February 9, 2023 | finance.yahoo.comSurgery Partners, Inc. Announces Fourth Quarter 2022 Earnings Release Date and Conference Call DetailsJanuary 25, 2023 | benzinga.comSurgery Partners Stock (NASDAQ:SGRY), Quotes and News SummaryJanuary 18, 2023 | markets.businessinsider.comAnalyst Expectations for Surgery Partners's FutureJanuary 11, 2023 | msn.comSurgery Partners reaffirms FY22 guidanceJanuary 9, 2023 | finance.yahoo.comSurgery Partners, Inc. Reaffirms 2022 Full Year GuidanceDecember 27, 2022 | finance.yahoo.comPrivate equity firms account for 48% of Surgery Partners, Inc.'s (NASDAQ:SGRY) ownership, while institutions account for 41%December 6, 2022 | msn.comSurgery Partners's Return On Capital Employed OverviewNovember 25, 2022 | benzinga.comBoard Member At This Health Care Company Buys $225.00M of StockNovember 24, 2022 | benzinga.com225.00M Reasons To Be Bullish On Surgery Partners StockSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SGRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address SGRY Company Calendar Last Earnings3/01/2023Today3/23/2023Next Earnings (Estimated)5/02/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry General medical & surgical hospitals Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SGRY CUSIPN/A CIK1638833 Webwww.surgerypartners.com Phone(615) 234-5900Fax615-234-5998Employees12,200Year FoundedN/APrice Target and Rating Average Stock Price Forecast$42.00 High Stock Price Forecast$56.00 Low Stock Price Forecast$35.00 Forecasted Upside/Downside+31.9%Consensus RatingModerate Buy Rating Score (0-4)2.71 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($0.58) Trailing P/E RatioN/A Forward P/E Ratio79.60 P/E GrowthN/ANet Income$-54,600,000.00 Net Margins-2.15% Pretax Margin4.34% Return on Equity-0.14% Return on Assets-0.05% Debt Debt-to-Equity Ratio0.87 Current Ratio1.87 Quick Ratio1.72 Sales & Book Value Annual Sales$2.54 billion Price / Sales1.58 Cash Flow$0.89 per share Price / Cash Flow35.73 Book Value$23.35 per share Price / Book1.36Miscellaneous Outstanding Shares126,030,000Free Float121,869,000Market Cap$4.01 billion OptionableOptionable Beta2.73 Key ExecutivesJ. Eric EvansChief Executive Officer & DirectorDavid T. DohertyChief Financial Officer & Executive Vice PresidentVarun GadhokChief Information Officer & Senior Vice PresidentRoxanne WomackChief Compliance Officer & Senior Vice PresidentJennifer B. BaldockSecretary, Chief Administrative Officer & EVPKey CompetitorsTenet HealthcareNYSE:THCUniversal Health ServicesNYSE:UHSBellRing BrandsNYSE:BRBRMerit Medical SystemsNASDAQ:MMSITeladoc HealthNYSE:TDOCView All CompetitorsInsiders & InstitutionsJason Eric EvansSold 99 sharesTotal: $2,979.90 ($30.10/share)Bradley R OwensSold 20 sharesTotal: $601.00 ($30.05/share)David T DohertySold 21 sharesTotal: $632.31 ($30.11/share)Jason Eric EvansSold 10,300 sharesTotal: $310,133.00 ($30.11/share)Bradley R OwensSold 1,669 sharesTotal: $50,236.90 ($30.10/share)View All Insider TransactionsView All Institutional Transactions SGRY Stock - Frequently Asked Questions Should I buy or sell Surgery Partners stock right now? 7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SGRY shares. View SGRY analyst ratings or view top-rated stocks. What is Surgery Partners' stock price forecast for 2023? 7 equities research analysts have issued twelve-month target prices for Surgery Partners' shares. Their SGRY share price forecasts range from $35.00 to $56.00. On average, they expect the company's share price to reach $42.00 in the next year. This suggests a possible upside of 31.9% from the stock's current price. View analysts price targets for SGRY or view top-rated stocks among Wall Street analysts. How have SGRY shares performed in 2023? Surgery Partners' stock was trading at $27.86 at the beginning of the year. Since then, SGRY stock has increased by 14.3% and is now trading at $31.84. View the best growth stocks for 2023 here. When is Surgery Partners' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 2nd 2023. View our SGRY earnings forecast. How were Surgery Partners' earnings last quarter? Surgery Partners, Inc. (NASDAQ:SGRY) issued its quarterly earnings results on Wednesday, March, 1st. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.06. The firm had revenue of $707.10 million for the quarter, compared to analyst estimates of $688.34 million. Surgery Partners had a negative net margin of 2.15% and a negative trailing twelve-month return on equity of 0.14%. What ETFs hold Surgery Partners' stock? ETFs with the largest weight of Surgery Partners (NASDAQ:SGRY) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), iShares U.S. Healthcare Providers ETF (IHF), First Trust Mid Cap Growth AlphaDEX Fund (FNY), Inspire Small/Mid Cap ETF (ISMD), Vanguard Health Care ETF (VHT) and Fidelity MSCI Health Care Index ETF (FHLC).Fidelity Blue Chip Growth ETF (FBCG) and What guidance has Surgery Partners issued on next quarter's earnings? Surgery Partners issued an update on its FY 2023 earnings guidance on Wednesday, March, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.75B-, compared to the consensus revenue estimate of $2.81 billion. What is Eric Evans' approval rating as Surgery Partners' CEO? 7 employees have rated Surgery Partners Chief Executive Officer Eric Evans on Glassdoor.com. Eric Evans has an approval rating of 86% among the company's employees. What other stocks do shareholders of Surgery Partners own? Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Sorrento Therapeutics (SRNE), Rigel Pharmaceuticals (RIGL), Ardelyx (ARDX), Glu Mobile (GLUU), Ocular Therapeutix (OCUL), Sangamo Therapeutics (SGMO), Xilinx (XLNX), Allena Pharmaceuticals (ALNA), Editas Medicine (EDIT) and Maxar Technologies (MAXR). What is Surgery Partners' stock symbol? Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY." Who are Surgery Partners' major shareholders? Surgery Partners' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Durable Capital Partners LP (6.51%), Clearbridge Investments LLC (6.09%), Avidity Partners Management LP (3.46%), Point72 Asset Management L.P. (2.44%), Dimensional Fund Advisors LP (1.39%) and Geode Capital Management LLC (1.18%). Insiders that own company stock include Anthony Taparo, Bradley R Owens, Brent Turner, Danielle Burkhalter, David T Doherty, George Goodwin, Jason Eric Evans, Jennifer Baldock, Laura L Brocklehurst, Laura L Brocklehurst, Marissa Brittenham, Teresa Deluca, Thomas F Cowhey and Wayne S Deveydt. View institutional ownership trends. How do I buy shares of Surgery Partners? Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Surgery Partners' stock price today? One share of SGRY stock can currently be purchased for approximately $31.84. How much money does Surgery Partners make? Surgery Partners (NASDAQ:SGRY) has a market capitalization of $4.01 billion and generates $2.54 billion in revenue each year. The company earns $-54,600,000.00 in net income (profit) each year or ($0.58) on an earnings per share basis. How many employees does Surgery Partners have? The company employs 12,200 workers across the globe. How can I contact Surgery Partners? Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The official website for the company is www.surgerypartners.com. The company can be reached via phone at (615) 234-5900, via email at ir@surgerypartners.com, or via fax at 615-234-5998. This page (NASDAQ:SGRY) was last updated on 3/23/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.